Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19232761rdf:typepubmed:Citationlld:pubmed
pubmed-article:19232761lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:19232761lifeskim:mentionsumls-concept:C0337810lld:lifeskim
pubmed-article:19232761lifeskim:mentionsumls-concept:C0021102lld:lifeskim
pubmed-article:19232761lifeskim:mentionsumls-concept:C0681698lld:lifeskim
pubmed-article:19232761lifeskim:mentionsumls-concept:C1511726lld:lifeskim
pubmed-article:19232761lifeskim:mentionsumls-concept:C1414461lld:lifeskim
pubmed-article:19232761lifeskim:mentionsumls-concept:C0243161lld:lifeskim
pubmed-article:19232761lifeskim:mentionsumls-concept:C0009563lld:lifeskim
pubmed-article:19232761lifeskim:mentionsumls-concept:C0180307lld:lifeskim
pubmed-article:19232761lifeskim:mentionsumls-concept:C0279776lld:lifeskim
pubmed-article:19232761lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:19232761pubmed:issue2lld:pubmed
pubmed-article:19232761pubmed:dateCreated2010-10-11lld:pubmed
pubmed-article:19232761pubmed:abstractTextThe follow-up of 1440 consecutive post-MI patients (68.9 ± 10.9 years) with an LVEF ? 40% was analyzed in 19 Italian hospitals to evaluate how many patients with clinical nonsustained VT and inducible sustained VT or VF underwent post-discharge risk assessment (RA). During 38 (range, 4-76) months follow-up, 611 patients (42.4%) qualified for and 294 (20.4%) effectively underwent RA combining LVEF assessment and Holter monitoring, 29 (2.0%) subsequently underwent programmed electrical stimulation and 19 (1.3%) received an ICD.lld:pubmed
pubmed-article:19232761pubmed:languageenglld:pubmed
pubmed-article:19232761pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19232761pubmed:citationSubsetIMlld:pubmed
pubmed-article:19232761pubmed:statusMEDLINElld:pubmed
pubmed-article:19232761pubmed:monthOctlld:pubmed
pubmed-article:19232761pubmed:issn1874-1754lld:pubmed
pubmed-article:19232761pubmed:authorpubmed-author:CoppolaAntoni...lld:pubmed
pubmed-article:19232761pubmed:authorpubmed-author:SinagraGianfr...lld:pubmed
pubmed-article:19232761pubmed:authorpubmed-author:CappatoRiccar...lld:pubmed
pubmed-article:19232761pubmed:authorpubmed-author:PecoraDomenic...lld:pubmed
pubmed-article:19232761pubmed:authorpubmed-author:MenozziCarloClld:pubmed
pubmed-article:19232761pubmed:authorpubmed-author:CurnisAntonio...lld:pubmed
pubmed-article:19232761pubmed:authorpubmed-author:SermasiSergio...lld:pubmed
pubmed-article:19232761pubmed:authorpubmed-author:ZanottoGabrie...lld:pubmed
pubmed-article:19232761pubmed:authorpubmed-author:LocatelliAles...lld:pubmed
pubmed-article:19232761pubmed:authorpubmed-author:SannaTommasoTlld:pubmed
pubmed-article:19232761pubmed:authorpubmed-author:RacitiGiovann...lld:pubmed
pubmed-article:19232761pubmed:authorpubmed-author:AccardiFrance...lld:pubmed
pubmed-article:19232761pubmed:authorpubmed-author:FreggiaroVale...lld:pubmed
pubmed-article:19232761pubmed:authorpubmed-author:PizzettiFabri...lld:pubmed
pubmed-article:19232761pubmed:authorpubmed-author:ZacconeGabrie...lld:pubmed
pubmed-article:19232761pubmed:copyrightInfoCopyright © 2009 Elsevier Ireland Ltd. All rights reserved.lld:pubmed
pubmed-article:19232761pubmed:issnTypeElectroniclld:pubmed
pubmed-article:19232761pubmed:day8lld:pubmed
pubmed-article:19232761pubmed:volume144lld:pubmed
pubmed-article:19232761pubmed:ownerNLMlld:pubmed
pubmed-article:19232761pubmed:authorsCompleteYlld:pubmed
pubmed-article:19232761pubmed:pagination268-9lld:pubmed
pubmed-article:19232761pubmed:meshHeadingpubmed-meshheading:19232761...lld:pubmed
pubmed-article:19232761pubmed:meshHeadingpubmed-meshheading:19232761...lld:pubmed
pubmed-article:19232761pubmed:meshHeadingpubmed-meshheading:19232761...lld:pubmed
pubmed-article:19232761pubmed:meshHeadingpubmed-meshheading:19232761...lld:pubmed
pubmed-article:19232761pubmed:meshHeadingpubmed-meshheading:19232761...lld:pubmed
pubmed-article:19232761pubmed:meshHeadingpubmed-meshheading:19232761...lld:pubmed
pubmed-article:19232761pubmed:meshHeadingpubmed-meshheading:19232761...lld:pubmed
pubmed-article:19232761pubmed:meshHeadingpubmed-meshheading:19232761...lld:pubmed
pubmed-article:19232761pubmed:year2010lld:pubmed
pubmed-article:19232761pubmed:articleTitleCompliance to MADIT and MUSTT criteria for implantable cardioverter defibrillator therapy in the pre-SCD-Heft and MADIT II era. Data from a multicenter Italian study.lld:pubmed
pubmed-article:19232761pubmed:publicationTypeLetterlld:pubmed
pubmed-article:19232761pubmed:publicationTypeMulticenter Studylld:pubmed